glp-1 and intermittent fasting Do GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide? Intermittent fasting alone: 1-3% weight

Obesity and overweight, which are common in patients with DM2, are a factors that favor the development/progression of CKD through both direct and indirect effects.69 Although the precise mechanisms the association between obesity and CKD are not totally defined it has been proposed that hypertension, glomerular hyperfiltration, hyperglycemia, lipid toxicity, inflammation or the role of adipose tissue and its adipokines are involved.70 Weight reduction by bariatric surgery, pharmacological treatment or dietary measures are associated with a nephroprotective effect,7173 so that weight reduction is a fundamental objective in the nephroprotection of patients with DKD

Choosing the Right Approach Not all peptides have the same level of research, regulatory approval, or clinical evidence

doi: 10.1007/s11515-014-1337-8 42

Leaders at CMS and the Department of Health and Human Services have highlighted the possibility that expanded access could ultimately save taxpayer dollars by lowering downstream medical spending

doi: 10.1038/s12276-023-01028-7 44 MorrisGBerkMGaleckiPWalderKMaesM

Patients consistently report decreased hunger, earlier satiety during meals, and reduced preoccupation with food